Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00577954
Other study ID # P051061
Secondary ID
Status Completed
Phase N/A
First received December 19, 2007
Last updated September 20, 2017
Start date October 2006
Est. completion date June 2014

Study information

Verified date December 2008
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Stroke, traumatic head injury, subarachnoid hemorrhage and cerebral anoxia are main causes of a coma condition implying severe brain damage and thus, poor prognosis. Clinicians are often in need for a tool able to predict the awakening of these patients. Multimodal MRI, associating the traditional morphological sequences with spectroscopy-MRI (MRS) and the diffusion tensor imaging, could provide such a prediction.


Description:

Predicting the awakening of patients in comas is one of the principal stakes of the current neurointensive care unit (neuroICU). Several studies and clinical practice suggest that the multimodal MRI, which associates the traditional morphological sequences (T1, T2*, FLAIR/T2), the spectroscopy-MRI (MRS) and the diffusion tensor imaging, is a tool allowing such a prediction. However, this strategy has not been yet validated. Additionally, currently there is no method of analysis including the 4 different sequences.

Objective: The goal of this study is to develop a composite score able to predict the awakening of coma patients following events such as a severe cranial trauma, ischemic or hemorrhagic cerebrovascular accident and cerebral anoxia. This composite score will be built from the results of the multimodal MRI (quantified indicator) in combination with clinical covariables (e.g., age of the patient, the mechanism of the accident (high versus low speed), etc.). The final score will aim to predict the outcome of patients at 1 year, evaluated by one of the following categories: favourable (Glasgow Outcome Scale (GOS 3+, 4, and 5) or unfavourable outcome (GOS 1, 2, and 3). GOS 3- score has been defined as minimally conscious state and GOS 3+ score as severe disability excluding cognitive sequelae.

MRI Analysis: The lesions present on the MRI will be quantified by a neuroradiologist and a dedicated clinical engineer from the coordination centre (Pitié-Salpêtrière Hospital) in a blinded way regarding patients' clinical data. Lesion load-indicators will be calculated on the sequences of FLAIR/T2, T2*, MRS and diffusion tensor imaging from a predefined analysis grid allowing the regional study of the lesions as well as the appreciation of their nature, their uni- or bilateral character and if bilateral, their symmetry.

Hypothesis and applicability: The multivariate analysis of morphological MRI, MRS and diffusion tensor imaging data, combined with the clinical covariables, will aim to develop a statistical algorithm, able to predict the clinical outcome of the patients. In the long term, it will be integrated into an expert system which will be the subject of a patent submission. The final objective is to provide the clinicians a diagnostic tool able to determine outcome of patients with severe cranial trauma and other neurological conditions such as stroke, subarachnoid hemorrhage and cerebral anoxia.


Recruitment information / eligibility

Status Completed
Enrollment 417
Est. completion date June 2014
Est. primary completion date March 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult affiliated to the social security system

- Hospitalized in neuroICU and requiring artificial ventilation following a severe cranial trauma, an ischemic and/or hemorrhagic cerebrovascular accident and/or a cerebral anoxia

- In coma defined as not answering simple orders at least 7 days after the event

- Receiving an amount of sedatives and not being able to explain the coma

- Having a standardized intracranial pressure (= 15 mm Hg) and in absence of severe hemodynamic or respiratory failure so that the MRI does not represent any additional danger

Exclusion Criteria:

- Coma of infectious or toxic origin

- Coma explained by sedation

- MRI contraindication (pace maker, medical material not MRI compatible)

- Persistent intracranial hypertension contraindicating the setting in prolonged dorsal decubitus (ICP > 20 mm Hg during more than 10 minutes after positioning on decubitus)

- Severe hemodynamic failure

- Severe respiratory failure

- Life threatening extra-cerebral lesions

- Cranial trauma of ballistic origin

- Patient presenting a severe compromise of a major function bringing into play the vital outcome, with invalidity before the accident/event

- Former neurological pathology altering the clinical outcome of the cranial trauma

- Refusal of the family

- Patient protected by the law (under supervision or trusteeship)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Multimodal MRI
Multimodal MRI

Locations

Country Name City State
France Assistance Publique Hopitaux de Paris Pitie Salpetriere Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary To define a quantified indicator resulting from the analysis of the multimodal MRI combined with clinical data to create a score to predict the 1 year outcome as measured by the dichotomized Glasgow Outcome Scale (extended version [GOSE]). one year
Secondary Relevance of the composite score to predict the clinical outcome at 1 year assessed by the Rankin score, the GOSE and the disability rating scale (DRS). one year
Secondary Intra and inter-observer reproducibility study of the analysis of the various sequences. during the study
See also
  Status Clinical Trial Phase
Completed NCT03504709 - REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness
Completed NCT04772547 - VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa Phase 2
Withdrawn NCT00593164 - Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients With Intravenous Infusion of Magnesium Sulfate Phase 2
Completed NCT02486211 - Amantadine to Speed Awakening After Cardiac Arrest Phase 2
Active, not recruiting NCT01239420 - Norwegian Cardio-Respiratory Arrest Study
Not yet recruiting NCT04584463 - Factors Associated With CPC 1-2 in 110 Patients Admitted in French ICU for a Myocardial Infarction Complicated by an OHCA.
Recruiting NCT02338284 - Optic Nerve Sheath Diameter as a Screening Test for Increased Intracranial Pressure N/A
Recruiting NCT05861323 - Feasibility of the Comfort Measures Only Time Out (CMOT) N/A
Not yet recruiting NCT06036732 - A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score
Active, not recruiting NCT03826407 - Development of a Point of Care System for Automated Coma Prognosis
Completed NCT03616054 - International Observational Study on Airway Management in Critically Ill Patients
Completed NCT00573014 - Cervical Spine Clearance in Obtunded Trauma Patients N/A
Completed NCT01973829 - The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN) N/A
Recruiting NCT06081283 - Antiseizure Medication in Seizure Networks at Early Acute Brain Injury Phase 4
Recruiting NCT05321459 - Predictive Outcome in Comatose Patients
Not yet recruiting NCT04623294 - Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy
Recruiting NCT04876222 - Direct or Subacute Coronary Angiography in Patients With Out of Hospital Cardiac Arrest Without Coma. N/A
Not yet recruiting NCT06321146 - Evaluation of EEG Power Spectrum in Patients With Traumatic Coma
Completed NCT03926494 - Carbon Monoxide-induced Coma: Prognostic Factors
Completed NCT00880204 - Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training N/A